Michael Roof has joined Iowa State University to serve as Chief Technology Officer (CTO) for the Vaccines and Immunotherapeutics research and innovation platform, which supports the state of Iowa’s biosciences-based economic growth initiative. In his role as CTO, Roof will lead efforts to identify and accelerate development of new technologies and innovations with strong commercial potential in the Vaccines and Immunotherapeutics platform. Dr. Roof’s updated contact details are available at aasv.org/directory. Are you on the move? If so, let us know at aasv@aasv.org.